1. Ukushoda kwezinsiza zokuhlonza i-nucleic acid kuzoba inkinga yomhlaba wonke.

2. Amabhizinisi aseShayina IVD anekhono lokuya phesheya futhi aqhudelane namabhizinisi asezingeni lomhlaba.

3, isiphithiphithi sokuhlola imakethe ye-reagent, isenzo esisemthethweni sokulawula izidakamizwa!

Amabhizinisi amaningi e-IVD athole iqoqo lokuqala lesitifiketi sangaphandle semikhiqizo yawo emisha ye-corona

Kuze kube manje, i-State Administration of Food and Drug Administration igunyaze amakhithi okuxilonga angu-20 ngaphandle-komzimba esimweni esiphuthumayo, okuhlanganisa ama-reagents okuthola i-nucleic acid angu-12 kanye nama-reagents angu-8 okuthola amasosha omzimba.
Ngokombiko we-West China Securities Research Report, umhlaba usebenzisa amakhithi okuhlola ama-nucleic acid angu-500,000 kuya ku-700,000 nsuku zonke. Ukushoda kwezinsiza zokuhlola i-nucleic acid kuzoba inkinga yomhlaba wonke, kanti isidingo samakhithi asebenza kahle kakhulu enziwe e-China kulindeleke ukuthi sihlale siphezulu.

Idatha yombiko wocwaningo ikhombisa ukuthi okungenani amazwe angama-26 athumele ama-oda wokuphakela eChina, kwa-odelwe amakhithi angaphezu kwezigidi eziyi-15. "Ukushoda okubalulekile kwezinsizakusebenza zokuthola i-Coronavirus kanye nemishini yokuzivikela KUKHONA akukaxazululwa," kusho isitatimende se-AMA ngoLwesibili.

Muva nje, inani lemikhiqizo emisha ye-IVD yebhizinisi ngesitifiketi sokuqala sangaphandle emakethe. Phakathi kwezinkampani ezisohlwini, okungenani izinkampani ezisohlwini eziyi-9, okuhlanganisa iMeikang Biotechnology, Peoson Biotechnology, Cape Biotechnology, Anke Biotechnology, Daan Genomics, Wanfu Biotechnology, Mike Biotechnology kanye neHangzhou Realytech, zithi imikhiqizo yazo isithole isitifiketi se-EU CE.

AusDiagnostics inc., Roche Diagnostics Inc., Vivacheck Inc., Zhijiang Group LTD., CTK Group LTD. (TGA) kanye neHollogier Group Inc. (TGA) ngoMgqibelo, Mashi 22, ngokusho kwe-Australian Drug Administration (TGA). I-Hangzhou Otai, i-Vivacheck ne-Shanghai Zhijiang ngamabhizinisi asekhaya e-IVD.

E-United States, ngokwesizindalwazi esisemthethweni se-FDA, ikhithi ye-fluorescent RT-PCR yesikhathi sangempela ekhiqizwe yi-BGI ukuze kutholwe i-SARS-2019-NCOV ivunyelwe yi-FDA futhi ingafakwa ngokusemthethweni ekuvimbeleni nasekulawuleni ubhubhane e-United States. Lona umkhiqizo wokuqala waseShayina odlulise isigunyazo esiphuthumayo se-FDA.
Eqinisweni, amabhizinisi aseChinese IVD anamandla okuya phesheya futhi ancintisane namabhizinisi asezingeni lomhlaba.

I-Hangzhou Realytech isiphumelele isitifiketi se-FDA. Izinga lokutholwa kwe-Coronavirus inoveli liphezulu. Sicela ukhululeke ukuxhumana nathi uma udingathenga i-reagent ebona ngokushesha i-coronavirus ngobuningi.